Eddie Blair PhD MBA has considerable experience in development and commercialisation of both therapeutics and diagnostics, and has an entrepreneurs eye for viable R&D projects and portfolio management having started-up and held several executive positions (CEO, CSO) in SMEs and AIM-listed companies, raising more than £15M in the process. Eddie has also held non-executive positions on the boards of private and public companies, specialising in remuneration matters, and lectured on Cambridge University's Masters in Bioscience Enterprise and MST in Genomic Medicine. He was a grant application assessor for UKRI, AsthmaUK and other charities. He has published more than 50 primary, peer-reviewed papers, including a series on companion diagnostic valuation, and is named inventor on at least one dozen patents. Eddie held extended contract positions at Bristol Myers Squibb, co-developing their biomarker strategy for immuno-oncology biotherapeutics, and at UCB Pharma, leading biomarker programmes associated with respiratory and neuroscience therapies. He is currently a Trustee Board Member at the Quadram Institute and is Vice-Chair of the Patient and Public Voice Panel for the NHS England East Genomic Medicine Service Alliance (EGMSA).